AI assistant
OPKO Health Inc. — Director's Dealing 2015
Sep 22, 2015
6963_rns_2015-09-22_03224ae4-3037-4f47-8e04-addab313e3d2.pdf
Director's Dealing
Open in viewerOpens in your device viewer
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
| 1. Name and Address of Reporting Person Paganelli John A | 2. Issuer Name and Ticker or Trading Symbol OPKO Health, Inc. [OPK] | 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) ☑ Director 10% Owner ☐ Officer (give title below) ☐ Other (specify below) | ||
|---|---|---|---|---|
| (Last) (First) (Middle) 1250 Pittsford-Victor Road Building 200 - Suite 280 | 3. Date of Earliest Transaction (Month/Day/Year) 09/18/2015 | |||
| (Street) Pittsford NY 14534 | 4. If Amendment, Date Original Filed (Month/Day/Year) | |||
| (City) (State) (Zip) | 6. Individual or Joint/Group Filing (Check Applicable Line) ☑ Form filed by One Reporting Person ☐ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
| 1. Title of Security (Instr. 3) | 2. Transaction Date (Month/Day/Year) | 2A. Deemed Execution Date, if any (Month/Day/Year) | 3. Transaction Code (Instr. 8) | 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) | 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) | 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Code | V | Amount | (A) or (D) | Price | ||||||
| Common Stock | 09/18/2015 | M | 5,000 | A | $0.41 | 304,725 | D | |||
| Common Stock | 09/18/2015 | M | 5,000 | A | $0.41 | 309,725 | D | |||
| Common Stock | 09/18/2015 | M | 5,000 | A | $0.39 | 314,725 | D | |||
| Common Stock | 09/18/2015 | M | 20,000 | A | $1.54 | 334,725 | D | |||
| Common Stock | 09/18/2015 | F | 3,517 (1) | D | $10.48 (2) | 331,208 | D | |||
| Common Stock | 4,175 | I | See Footnote (3) |
Form 4 (continued)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
| 1. Title of Derivative Security (Instr. 3) | 2. Conversion or Exercise Price of Derivative Security | 3. Transaction Date (Month/Day/Year) | 3A. Deemed Execution Date, if any (Month/Day/Year) | 4. Transaction Code (Instr. 8) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5) | 6. Date Exercisable and Expiration Date (Month/Day/Year) | 7. Title and Amount of Underlying Securities (Instr. 3 and 4) | 8. Price of Derivative Security (Instr. 5) | 9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
| Stock Option (Right to Buy) | $0.41 | 09/18/2015 | M | 5,000 | 01/03/2006 | 01/02/2016 | Common Stock | 5,000 | $ 0 | 0 | D | ||||
| Stock Option (Right to Buy) | $0.41 | 09/18/2015 | M | 5,000 | 04/03/2006 | 04/02/2016 | Common Stock | 5,000 | $ 0 | 0 | D | ||||
| Stock Option (Right to Buy) | $0.39 | 09/18/2015 | M | 5,000 | 07/03/2006 | 07/03/2016 | Common Stock | 5,000 | $ 0 | 0 | D | ||||
| Stock Option (Right to Buy) | $1.54 | 09/18/2015 | M | 20,000 | 06/10/2010 | 06/09/2016 | Common Stock | 20,000 | $ 0 | 0 | D |
Explanation of Responses:
(1) Represents number of shares withheld by the Company at the direction of the reporting person for the payment of exercise price. No shares of Common Stock were sold by the reporting person in connection with this transaction. The reporting person has retained the net number of shares issued upon the exercise of the options (31,483 shares).
(2) Closing market price of the Company's common stock on the transaction date.
(3) These securities are owned by Mr. Paganelli's spouse. The reporting person disclaims beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purposes.
Adam Logal, Attorney-In-Fact Signature of Reporting Person 09/22/2015 Date
- If the form is filed by more than one reporting person, see Instruction 4(b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.